Product logins

Find logins to all Clarivate products below.


Open Surgery Instruments | Market Insights | Asia Pacific (Supplemental) | 2021

Although it will be negatively impacted in the short term by the COVID-19 pandemic, the Asia Pacific open surgery instrument market will grow moderately through 2029. Emerging economies will be major centers of growth due to their improving health care infrastructure and promising economic and demographic landscapes. Additionally, the mature markets will grow, primarily as a result of demand for innovative and premium-priced products, especially in the direct energy device segment.

This Medtech 360 Report provides high-level market metrics for the open surgery instrument market in Asia Pacific, including country-level data for major countries and aggregate data for the rest of Asia Pacific, across a 10-year period.

Related Medtech Insights Reports

Report
Cardiac Rhythm Management Devices – Market Insights – Asia Pacific
The Asia Pacific CRM device market will register modest growth over the forecast period. Key growth drivers include the rising adoption of premium-priced technologies such as CRT devices, leadless…
Report
Aortic Repair Devices – Market Insights – Asia Pacific
The Asia Pacific aortic repair device market is projected to experience robust growth during the forecast period, fueled by rising endovascular procedure volumes, ongoing innovation in aortic stent…
Report
Cardiac Rhythm Management Devices | Market Insights | Asia Pacific (Supplemental) | 2025
The Asia Pacific CRM device market will experience modest growth over the forecast period, driven primarily by the increasing volume of ICM procedures and the adoption of premium-priced devices,…
Report
Biosurgical Agents – Market Insights – Asia Pacific
The biosurgical agent market in Asia Pacific will experience modest growth through 2034, driven by rising surgical procedure volumes and expanding use of biosurgical agents across a broader range…
Report
Structural Heart Closure Devices – Market Insights – Asia Pacific
The Asia Pacific structural heart closure device market will grow strongly overall through 2034, supported by rising AF prevalence, increasing physician confidence in structural heart interventions…